Not applicableStudy completedNCT00213564
What this trial is testing
Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
Who this might be right for
Rheumatoid Arthritis
University Hospital, Rouen 40